Cite
Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers: Anti-arrhythmic Drug for Arrhythmogenic Right Ventricular Cardiomyopathy
MLA
Limin Liu, et al. “Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers: Anti-Arrhythmic Drug for Arrhythmogenic Right Ventricular Cardiomyopathy.” Frontiers in Cardiovascular Medicine, vol. 8, Nov. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....257d79e0a0e7bb74b79ec82fcab46109&authtype=sso&custid=ns315887.
APA
Limin Liu, Lishui Sheng, Zhenghui Zhu, Shangyu Liu, Lihui Zheng, Bin Tu, Yan Yao, & Lingmin Wu. (2021). Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers: Anti-arrhythmic Drug for Arrhythmogenic Right Ventricular Cardiomyopathy. Frontiers in Cardiovascular Medicine, 8.
Chicago
Limin Liu, Lishui Sheng, Zhenghui Zhu, Shangyu Liu, Lihui Zheng, Bin Tu, Yan Yao, and Lingmin Wu. 2021. “Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers: Anti-Arrhythmic Drug for Arrhythmogenic Right Ventricular Cardiomyopathy.” Frontiers in Cardiovascular Medicine 8 (November). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....257d79e0a0e7bb74b79ec82fcab46109&authtype=sso&custid=ns315887.